
IRLAB granted additional patent for its drug candidate pirepemat expanding the patent protection in the US
IRLAB granted additional patent for its drug candidate pirepemat expanding the patent protection in the US
Gothenburg, Sweden, September 18, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that a new patent has been granted in the US covering a salt of the drug candidate pirepemat. The patent covers the active pharmaceutical ingredient used in the ongoing clinical development of pirepemat.
“The patent granted today is an important addition to IRLAB’s already strong patent portfolio for pirepemat. The patent portfolio allows for a potential market exclusivity reaching into the early 2040s in most of the key geographies. The granting of this new patent brings a substantial increase in commercial value of the pirepemat program, ” said Kristina Torfgård, CEO of IRLAB.
Pirepemat has the potential to become the first treatment in a new class of drugs designed to reduce falls, and thus fall injuries, in people living with Parkinson’s disease.
The latest patent, covering the salt of the drug used in the ongoing clinical development, has previously been granted in Europe, Japan and China, predicted to expire in 2038. With the awarded patent term adjustment (PTA) and potential grant of patent term extension (PTE), exclusivity in the US will reach into the early 2040s.
Pirepemat has previously been granted composition of matter patents, providing pirepemat exclusivity in all the major markets such as China, Europe, Japan, and the US. Furthermore, a patent directed to the process for the preparation of pirepemat has recently been granted in the US.
Latest Posts
- US believes Iran hasn’t decided to build a nuclear weapon
October 11, 2024 | Breaking News, United States of America, World - Fake Microsoft Support Racket Targeting US Citizens Busted In Bengaluru, 21 Arrested
November 16, 2025 | Breaking News, India - J&K Journalist Sulinder Parihar Sarazi Honoured at Punjab’s Kirpal Sagar Academy
November 15, 2025 | Doda, Jammu Kashmir - Centre Launches 10 New AMRIT Pharmacies to Boost Access to Affordable Medicines
November 15, 2025 | Breaking News, India, Politics - Kannada Actress Accuses Businessman of Harassment, Stalking and Assault
November 15, 2025 | Breaking News, Entertainment - Blue Origin Launches New Glenn on First Customer Mission, Sends NASA Mars Satellites on 22-Month Journey
November 15, 2025 | Breaking News, Technology, World - Akasa Air to Launch First Commercial Flights From Navi Mumbai International Airport on December 25, 2025
November 15, 2025 | Breaking News, India - Counting Begins for By-Elections Across Six States and J&K
November 14, 2025 | Breaking News, India, Politics - Fire Engulfs Gawari Market in Bhallesa Doda, Nearly 10 Setups Gutted
November 11, 2025 | Breaking News, Doda, Jammu Kashmir - CropLife International elects Corteva CEO Chuck Magro as new Chairman of the Board
November 10, 2025 | Breaking News, World - Pakistan Amends Constitution, Gives Asim Munir Key Role After Op Sindoor Drubbing
November 9, 2025 | Breaking News, Politics, World
